1. Home
  2. SRPT vs PRGS Comparison

SRPT vs PRGS Comparison

Compare SRPT & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • PRGS
  • Stock Information
  • Founded
  • SRPT 1980
  • PRGS 1981
  • Country
  • SRPT United States
  • PRGS United States
  • Employees
  • SRPT N/A
  • PRGS N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • PRGS Computer Software: Prepackaged Software
  • Sector
  • SRPT Health Care
  • PRGS Technology
  • Exchange
  • SRPT Nasdaq
  • PRGS Nasdaq
  • Market Cap
  • SRPT 1.9B
  • PRGS 1.8B
  • IPO Year
  • SRPT 1997
  • PRGS 1991
  • Fundamental
  • Price
  • SRPT $17.65
  • PRGS $42.14
  • Analyst Decision
  • SRPT Hold
  • PRGS Strong Buy
  • Analyst Count
  • SRPT 30
  • PRGS 5
  • Target Price
  • SRPT $35.93
  • PRGS $68.00
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • PRGS 618.1K
  • Earning Date
  • SRPT 11-03-2025
  • PRGS 09-29-2025
  • Dividend Yield
  • SRPT N/A
  • PRGS N/A
  • EPS Growth
  • SRPT N/A
  • PRGS N/A
  • EPS
  • SRPT N/A
  • PRGS 1.09
  • Revenue
  • SRPT $2,413,715,000.00
  • PRGS $940,126,000.00
  • Revenue This Year
  • SRPT $10.20
  • PRGS $32.42
  • Revenue Next Year
  • SRPT N/A
  • PRGS $1.44
  • P/E Ratio
  • SRPT N/A
  • PRGS $38.69
  • Revenue Growth
  • SRPT 47.15
  • PRGS 31.41
  • 52 Week Low
  • SRPT $10.42
  • PRGS $40.29
  • 52 Week High
  • SRPT $138.81
  • PRGS $70.56
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 38.30
  • PRGS 40.50
  • Support Level
  • SRPT $15.08
  • PRGS $41.92
  • Resistance Level
  • SRPT $18.80
  • PRGS $43.44
  • Average True Range (ATR)
  • SRPT 1.40
  • PRGS 1.20
  • MACD
  • SRPT -0.84
  • PRGS -0.32
  • Stochastic Oscillator
  • SRPT 24.92
  • PRGS 14.38

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About PRGS Progress Software Corporation (DE)

Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.

Share on Social Networks: